Ac immune announces upcoming presentations and industry symposium on active immunotherapies at ad/pd™ 2025

Ac immune announces upcoming presentations and industry symposium on active immunotherapies at ad/pd™ 2025 ac immune to host symposium highlighting the company's industry-leading pipeline of active immunotherapies for precision prevention of neurodegenerative diseases multiple presentations at the international conference on alzheimer's and parkinson's disease (ad/pd™ 2025) showcasing the diversity of the company's precision medicine pipeline lausanne, switzerland, march 25, 2025 – ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced upcoming presentations highlighting its precision medicine pipeline at the international conference on alzheimer's and parkinson's diseases (ad/pd™ 2025) taking place in vienna, austria, on april 1 – 5, 2025. ac immune will host an industry symposium highlighting advances in the clinical development of active immunotherapies featuring key opinion leaders, industry experts and ac immune leadership.
ACIU Ratings Summary
Quant
ACIU Quant Ranking
Sector
Industry
Quant Rating
Quant Score